Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 21791-21792 [2019-09971]
Download as PDF
<![CDATA[
21791
Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices
respond to requests from HHS,
Congress, and others.
Likely Respondents: RWHAP AETC
trainees are asked to complete the PIF
either at the start or at conclusion of an
event. Trainers are asked to complete an
ER for each training event they conduct
during the year. In addition, each
regional RWHAP AETC (eight total) and
the RWHAP AETC National
Coordinating Resource Center will
compile these data into a data set and
submit to HRSA HAB once a year.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
Number of
respondents
Form name
Number of
responses
per
respondent
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
The estimated annual response
burden to trainers, as well as trainees of
training programs is follows:
Average
burden per
response
(in hours)
Total
responses
Total
burden hours
Participant Information Form (PIF) ......................................
Event Record (ER) ...............................................................
61,288
10,522
1
1
61,288
10,522
0.05
0.13
3,064
1,368
Total ..............................................................................
71,810
........................
71,810
........................
4,432
The estimated annual burden to
RWHAP AETCs is as follows:
Number of
respondents
Responses
per
respondent
Total
responses
Hours
per response
Total burden
hours
9
1
9
10
90
Aggregate Data Set .............................................................
Amy P. McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2019–09976 Filed 5–14–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on Combating AntibioticResistant Bacteria
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that a meeting is scheduled to be held
for the Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria
(Advisory Council). The meeting will be
open to the public; a public comment
session will be held during the meeting.
Pre-registration is required for members
of the public who wish to attend the
meeting and who wish to participate in
the public comment session. Individuals
who wish to attend the meeting and/or
send in their public comment via email
jbell on DSK3GLQ082PROD with NOTICES
VerDate Sep<11>2014
22:43 May 14, 2019
Jkt 247001
FOR FURTHER INFORMATION CONTACT:
The meeting is scheduled to be
held on July 10, 2019, from 9:00 a.m. to
5:00 p.m. and July 11, 2019, from 9:00
a.m. to 5:00 p.m. ET (times are tentative
and subject to change). The confirmed
times and agenda items for the meeting
will be posted on the website for the
Advisory Council at https://
www.hhs.gov/ash/carb/ when this
information becomes available. Preregistration for attending the meeting in
person is required to be completed no
later than July 2, 2019; public
attendance at the meeting is limited to
the available space.
SUPPLEMENTARY INFORMATION:
DATES:
AGENCY:
SUMMARY:
should send an email to CARB@hhs.gov.
Registration information is available on
the website https://www.hhs.gov/ash/
carb/ and must be completed by July 2,
2019; all in-person attendees must preregister by this date. Additional
information about registering for the
meeting and providing public comment
can be obtained at https://www.hhs.gov/
ash/carb/ on the Meetings page.
Hilton McLean Tysons
Corner, International Ballroom C, 7920
Jones Branch Dr., McLean, VA 22102.
The meeting can also be accessed
through a live webcast and via
teleconference on the day of the
meeting. For more information, visit
https://www.hhs.gov/ash/carb/.
ADDRESSES:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Jomana Musmar, Designated Federal
Officer, Presidential Advisory Council
on Combating Antibiotic-Resistant
Bacteria, Office of the Assistant
Secretary for Health, U.S. Department of
Health and Human Services, Room
L133, Switzer Building, 330 C St. SW,
Washington, DC 20201. Phone Number:
(202) 795–7678. Email: CARB@hhs.gov.
Under
Executive Order 13676, dated
September 18, 2014, authority was given
to the Secretary of HHS to establish the
Advisory Council, in consultation with
the Secretaries of Defense and
Agriculture. Activities of the Advisory
Council are governed by the provisions
of Public Law 92–463, as amended (5
U.S.C. App.), which sets forth standards
for the formation and use of federal
advisory committees.
The Advisory Council will provide
advice, information, and
recommendations to the Secretary of
HHS regarding programs and policies
intended to support and evaluate the
implementation of Executive Order
13676, including the National Strategy
for Combating Antibiotic-Resistant
Bacteria and the National Action Plan
for Combating Antibiotic-Resistant
Bacteria. The Advisory Council shall
function solely for advisory purposes.
E:\FR\FM\15MYN1.SGM
15MYN1
jbell on DSK3GLQ082PROD with NOTICES
21792
Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices
In carrying out its mission, the
Advisory Council will provide advice,
information, and recommendations to
the Secretary regarding programs and
policies intended to preserve the
effectiveness of antibiotics by
optimizing their use; advance research
to develop improved methods for
combating antibiotic resistance and
conducting antibiotic stewardship;
strengthen surveillance of antibioticresistant bacterial infections; prevent
the transmission of antibiotic-resistant
bacterial infections; advance the
development of rapid point-of-care and
agricultural diagnostics; further research
on new treatments for bacterial
infections; develop alternatives to
antibiotics for agricultural purposes;
maximize the dissemination of up-todate information on the appropriate and
proper use of antibiotics to the general
public and human and animal
healthcare providers; and improve
international coordination of efforts to
combat antibiotic resistance.
The public meeting will be dedicated
to the council’s deliberation and vote on
the National Action Plan (NAP) on
Combating Antibiotic Resistance
Bacteria (CARB) 2019 Working Group’s
(WG) report out on their draft response
to the Secretary of the Department of
Health and Human Services (HHS) on
identifying priority areas for the next
iteration of the NAP on CARB, 2020–
2025. The remainder of the two-day
public meeting will include panel
presentations and council discussions
surrounding emerging antifungals, and
provider challenges and educational
solutions to influence antibiotic
stewardship and One Health. The
meeting agenda will be posted on the
Advisory Council website at https://
www.hhs.gov/ash/carb/ when it has
been finalized. All agenda items are
tentative and subject to change.
Public attendance at the meeting is
limited to the available space.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Advisory Council at the
address/telephone number listed above
at least one week prior to the meeting.
For those unable to attend in person, a
live webcast will be available. More
information on registration and
accessing the webcast can be found at
https://www.hhs.gov/ash/carb/.
Members of the public will have the
opportunity to provide comments prior
to the Advisory Council meeting by
emailing CARB@hhs.gov. Public
comments should be sent in by
midnight July 2, 2019, and should be
limited to no more than one page. All
VerDate Sep<11>2014
22:43 May 14, 2019
Jkt 247001
public comments received prior to July
2, 2019, will be provided to Advisory
Council members; comments are limited
to five minutes per speaker.
Dated: May 2, 2019.
Jomana F. Musmar,
Designated Federal Officer, Presidential
Advisory Council on Combating AntibioticResistant Bacteria, Committee Manager.
[FR Doc. 2019–09971 Filed 5–14–19; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Establishment of the Interdepartmental
Substance Use Disorders Coordinating
Committee and Solicitation of
Nominations for Committee Members
Office of the Assistant
Secretary for Health, Office of the
Secretary, U.S. Department of Health
and Human Services.
ACTION: Notice.
AGENCY:
The U.S. Department of
Health and Human Services (HHS)
hereby announces the establishment of
the Interdepartmental Substance Use
Disorders Coordinating Committee
(Committee) pursuant to Section 7022 of
the Substance Use-Disorder Prevention
that Promotes Opioid Recovery and
Treatment for Patients and Communities
Act. The Committee will consist of
representatives of specific federal
agencies and non-federal individuals
and entities who represent diverse
disciplines and views. The Committee
will identify areas for improved
coordination related to substance abuse,
including research, services, supports
and prevention activities across all
relevant Federal agencies. In identifying
areas for coordination, the committee
will provide recommendations for
improving Federal programs for the
prevention and treatment of, and
recovery from, substance use disorders,
including by expanding access to
prevention, treatment and recovery
services. They will also analyze
substance use disorder prevention and
treatment strategies in different regions
of and populations in the United States
and evaluate the extent to which
Federal substance use disorder and
treatment strategies are aligned with
State and local substance disorder and
treatment strategies.
Through this notice, HHS is also
requesting nominations of individuals
who are interested in being considered
for appointment to the Committee.
Resumes or curricula vitae from
qualified individuals who wish to be
considered for appointment as a
SUMMARY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
member of the Committee are currently
being accepted.
DATES: Nominations must be received
no later than 11:59 p.m. June 14, 2019.
ADDRESSES: All nominations must be
submitted via email at SUDCommittee@
hhs.gov with the subject line:
Interdepartmental SUD Coordinating
Committee.
FOR FURTHER INFORMATION CONTACT:
Roula K. Sweis, Psy.D., M.A., Chief,
Operations and Management, Office of
the Assistant Secretary for Health; U.S.
Department of Health and Human
Services; Telephone: 202–260–6619;
Fax: 202–690–4631; Email address:
SUDCommittee@hhs.gov (please
indicate in the subject line:
Interdepartmental SUD Coordinating
Committee). The Committee charter may
be accessed online at https://
www.hhs.gov/ash/advisory-committees/
substance-use-disorders/.
The charter includes detailed
information about the purpose,
function, and structure of the
Committee.
Section
7022 of the Substance Use-Disorder
Prevention that Promotes Opioid
Recovery and Treatment for Patients
and Communities Act (SUPPORT Act,
Pub. L. 115–271) requires the HHS
Secretary, in coordination with the
Director of National Drug Control
Policy, to establish the
Interdepartmental Substance Use
Disorders Coordinating Committee. The
Committee will consist of
representatives of specific federal
agencies and non-federal individuals
and entities who represent diverse
disciplines and views. The Committee
will identify areas for improved
coordination related to substance abuse,
including research, services, supports
and prevention activities across all
relevant Federal agencies. In identifying
areas for coordination, the committee
will provide recommendations for
improving Federal programs for the
prevention and treatment of, and
recovery from, substance use disorders,
including by expanding access to
prevention, treatment and recovery
services. They will also analyze
substance use disorder prevention and
treatment strategies in different regions
of and populations in the United States
and evaluate the extent to which
Federal substance use disorder and
treatment strategies are aligned with
State and local substance disorder and
treatment strategies.
Objectives and Scope of Activities.
The Committee will perform the
following duties:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 84, Number 94 (Wednesday, May 15, 2019)]
[Notices]
[Pages 21791-21792]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-09971]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that a meeting is scheduled to be held for the Presidential Advisory
Council on Combating Antibiotic-Resistant Bacteria (Advisory Council).
The meeting will be open to the public; a public comment session will
be held during the meeting. Pre-registration is required for members of
the public who wish to attend the meeting and who wish to participate
in the public comment session. Individuals who wish to attend the
meeting and/or send in their public comment via email should send an
email to [email protected]. Registration information is available on the
website https://www.hhs.gov/ash/carb/ and must be completed by July 2,
2019; all in-person attendees must pre-register by this date.
Additional information about registering for the meeting and providing
public comment can be obtained at https://www.hhs.gov/ash/carb/ on the
Meetings page.
DATES: The meeting is scheduled to be held on July 10, 2019, from 9:00
a.m. to 5:00 p.m. and July 11, 2019, from 9:00 a.m. to 5:00 p.m. ET
(times are tentative and subject to change). The confirmed times and
agenda items for the meeting will be posted on the website for the
Advisory Council at https://www.hhs.gov/ash/carb/ when this information
becomes available. Pre-registration for attending the meeting in person
is required to be completed no later than July 2, 2019; public
attendance at the meeting is limited to the available space.
ADDRESSES: Hilton McLean Tysons Corner, International Ballroom C, 7920
Jones Branch Dr., McLean, VA 22102.
The meeting can also be accessed through a live webcast and via
teleconference on the day of the meeting. For more information, visit
https://www.hhs.gov/ash/carb/.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, Designated Federal
Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, Room L133, Switzer Building,
330 C St. SW, Washington, DC 20201. Phone Number: (202) 795-7678.
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September
18, 2014, authority was given to the Secretary of HHS to establish the
Advisory Council, in consultation with the Secretaries of Defense and
Agriculture. Activities of the Advisory Council are governed by the
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets
forth standards for the formation and use of federal advisory
committees.
The Advisory Council will provide advice, information, and
recommendations to the Secretary of HHS regarding programs and policies
intended to support and evaluate the implementation of Executive Order
13676, including the National Strategy for Combating Antibiotic-
Resistant Bacteria and the National Action Plan for Combating
Antibiotic-Resistant Bacteria. The Advisory Council shall function
solely for advisory purposes.
[[Page 21792]]
In carrying out its mission, the Advisory Council will provide
advice, information, and recommendations to the Secretary regarding
programs and policies intended to preserve the effectiveness of
antibiotics by optimizing their use; advance research to develop
improved methods for combating antibiotic resistance and conducting
antibiotic stewardship; strengthen surveillance of antibiotic-resistant
bacterial infections; prevent the transmission of antibiotic-resistant
bacterial infections; advance the development of rapid point-of-care
and agricultural diagnostics; further research on new treatments for
bacterial infections; develop alternatives to antibiotics for
agricultural purposes; maximize the dissemination of up-to-date
information on the appropriate and proper use of antibiotics to the
general public and human and animal healthcare providers; and improve
international coordination of efforts to combat antibiotic resistance.
The public meeting will be dedicated to the council's deliberation
and vote on the National Action Plan (NAP) on Combating Antibiotic
Resistance Bacteria (CARB) 2019 Working Group's (WG) report out on
their draft response to the Secretary of the Department of Health and
Human Services (HHS) on identifying priority areas for the next
iteration of the NAP on CARB, 2020-2025. The remainder of the two-day
public meeting will include panel presentations and council discussions
surrounding emerging antifungals, and provider challenges and
educational solutions to influence antibiotic stewardship and One
Health. The meeting agenda will be posted on the Advisory Council
website at https://www.hhs.gov/ash/carb/ when it has been finalized. All
agenda items are tentative and subject to change.
Public attendance at the meeting is limited to the available space.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the Advisory Council at the address/telephone number listed
above at least one week prior to the meeting. For those unable to
attend in person, a live webcast will be available. More information on
registration and accessing the webcast can be found at https://www.hhs.gov/ash/carb/.
Members of the public will have the opportunity to provide comments
prior to the Advisory Council meeting by emailing [email protected]. Public
comments should be sent in by midnight July 2, 2019, and should be
limited to no more than one page. All public comments received prior to
July 2, 2019, will be provided to Advisory Council members; comments
are limited to five minutes per speaker.
Dated: May 2, 2019.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Committee Manager.
[FR Doc. 2019-09971 Filed 5-14-19; 8:45 am]
BILLING CODE 4150-44-P
